Correlation Between Surrozen and ABVC Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Surrozen and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Surrozen and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Surrozen and ABVC Biopharma, you can compare the effects of market volatilities on Surrozen and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Surrozen with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Surrozen and ABVC Biopharma.

Diversification Opportunities for Surrozen and ABVC Biopharma

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Surrozen and ABVC is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Surrozen and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Surrozen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Surrozen are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Surrozen i.e., Surrozen and ABVC Biopharma go up and down completely randomly.

Pair Corralation between Surrozen and ABVC Biopharma

Given the investment horizon of 90 days Surrozen is expected to generate 2.11 times more return on investment than ABVC Biopharma. However, Surrozen is 2.11 times more volatile than ABVC Biopharma. It trades about 0.01 of its potential returns per unit of risk. ABVC Biopharma is currently generating about -0.36 per unit of risk. If you would invest  970.00  in Surrozen on August 28, 2024 and sell it today you would lose (61.00) from holding Surrozen or give up 6.29% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Surrozen  vs.  ABVC Biopharma

 Performance 
       Timeline  
Surrozen 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Surrozen are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Surrozen may actually be approaching a critical reversion point that can send shares even higher in December 2024.
ABVC Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABVC Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Surrozen and ABVC Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Surrozen and ABVC Biopharma

The main advantage of trading using opposite Surrozen and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Surrozen position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.
The idea behind Surrozen and ABVC Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios